Daily Dose: 10/16/12

     Stay away from the Mini-Wheats: Attention, all cereal lovers! Kellogg’s has issued a recall of its Mini-Wheats products “due to the possible presence of fragments of flexible metal mesh,” according to a statement issued by the company. Kellogg’s is working with their metal detector supplier to try to figure out why the mesh fragments were undetected. Frosted Mini-Wheats Bite Size (Original) and Mini-Wheats Unfrosted Bite Size with the letters KB, AP or FK before or after the “Best if Used Before” date are among the products included in the recall.

New Treatment for Lung Cancer: The FDA approved the use of the breast cancer drug Abraxane to treat non-small cell lung cancer, the most common type of lung cancer. Patients with metastatic breast cancer are treated with Abraxane when other treatments don’t work. The drug works with the cancer chemotherapy paclitaxel and albumin (protein), which deliver an increased amount of chemotherapy to fight cancer with fewer side effects.

Confusion About Chemotherapy: A new study in the journal Cancer shows people undergoing chemotherapy treatment for cancer don’t understand its role in their treatment plan. Authors of the study surveyed 125 diagnosed cancer patients and their doctors. The goal of the study was to find out if both doctor and patient gave the same answer when asked how chemotherapy can help the patient. 24 percent of the patients gave different answers than their doctors when asked how chemotherapy can help them. The study also found that people who received materials outlining their care were three times more likely to understand their treatment.